Pure Global
NCT06045390

An App-based Instructional Platform to Improve Eye Drop Recall

Assessing the Effects of an In-office, Language-concordant App on Eye Drop Recall in Patients With Multi-drop Regimens
University of California, San Francisco·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Glaucoma
Drug/Device/Intervention
App
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
University of California, San Francisco
Location
San Francisco, United States of America
Timeline & enrollment
Phase
N/A
Start date
Oct 01, 2023
End date
Sep 01, 2024
Enrollment
80 participants
Primary outcome

Percentage accuracy of drop regimen recall

Summary

The goal of this interventional study is to assess whether an in-office, language-concordant
 instructional app improves drop regimen recall in a population of glaucoma patients who are
 on multi-drop regimens.
 
 Participants will be divided into two groups -- those who use the app and those who do not.
 The app will have narrated information regarding the drop regimen, a quiz to test
 understanding of the regimen, and will enable a graphical printout of the eye drops and
 schedule.
 
 At one month, both groups will be assessed on their eye drop regimen recall.

ICD-10 classifications
GlaucomaGlaucomaOther glaucomaGlaucoma, unspecifiedGlaucoma in diseases classified elsewhere
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06045390
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06045390 through Pure Global AI's free database. This phase not specified trial is sponsored by University of California, San Francisco and is currently Not yet recruiting. The study focuses on Glaucoma. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.